GE Analytical Instruments Knowledge Center

 
GE Analytical Instruments Knowledge Center

GE Analytical Instruments, a division of GE Water & Process Technologies, manufactures the world's most sensitive, selective and robust scientific instruments and is the leading provider of Total Organic Carbon Analyzers to the pharmaceutical industry. Pharmaceutical and biopharmaceutical companies worldwide rely upon the Sievers brand of TOC analyzers for monitoring pharmaceutical waters for USP, EP and JP compliance in lab and process environments, and for process analytical technology (PAT) and other quality initiatives such as on-line compendial water release and cleaning validation.

Sievers TOC Analyzers are based on patented membrane conductometric detection technology and are known for their superior analytical performance, high automation and ease of use. New models include the reagentless 500 RL On-Line TOC Analyzer and the application-specific 900 Series (Portable, Laboratory and On-Line).

Other pharmaceutical industry products include the new battery-powered CheckPoint Portable/On-Line TOC Sensor, the Cleaning Validation Support Package (CVSP), Sievers TOC Standards and Sievers Certified (<10 ppb)TOC Vials.

Quick Facts

  • GE Analytical Instruments
  • 6060 Spine Road
  • Boulder, Co. 80301
  • USA

Table of Contents

Podcasts

Back to Top

White Papers

Quality Circle: A Primer for Business Performance Management

What has emerged from Pharma's tough journey is a newfound appreciation for business performance.

Click Here

Crazy Like a Fox

New paradigms are needed if PAT’s promise is to be realized for biopharma process control.

Click Here

Therapeutic Dose: Good Enough is Not Good Enough

As mom used to say on my report card: you could do better.

Click Here

Anticounterfeiting the Focus of USP Science Meeting

Raman, and What It Still Needs, Highlight Discussions

Click Here
Back to Top

Application Notes

Digital Insights: At Last: Potential FDA Guidance on Web 2.0 & Social Media

Without any clear-cut guidance, pharma companies have been struggling for years with how they will engage the drug industry on the web and via popular social media sites without violating FDA regulations.

Click Here

From the Editor: Gobsmacked

Market forces already demand a smarter management style, better technology and a science-based quality toolkit, for both name-brand and generics

Click Here

Therapeutic Dose: When You Have Fired the Crew, Who Will Row the Boat?

Without a full complement of scientists, where will the spinoffs and innovative side benefits come from?

Click Here

USP Presents Heparin Quality Standards

Small but necessary steps towards new and improved standards

Click Here

Changing the Game: Open Data Integration for PAT

Now that OPC’s Analyzer Device Integration model is reality, what can we expect?

Click Here
Back to Top